{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:03:24Z","timestamp":1788264204490,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["5R33HL166441-03"],"award-info":[{"award-number":["5R33HL166441-03"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ahj.2024.05.012","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T16:58:19Z","timestamp":1716569899000},"page":"74-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial)"],"prefix":"10.1016","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-818X","authenticated-orcid":false,"given":"Joselyn","family":"Rwebembera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ndagire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison R.","family":"Webel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Sable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy","family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Sarnacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Spaziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atukunda","family":"Mucunguzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Grobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Beaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2024.05.012_bib0001","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2024.05.012_bib0002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5334\/gh.529","article-title":"Cost-effectiveness of rheumatic heart disease echocardiographic screening in Brazil: data from the PROVAR+ study: cost-effectiveness of RHD screening in Brazil","volume":"15","author":"Ubels","year":"2020","journal-title":"Glob Heart"},{"key":"10.1016\/j.ahj.2024.05.012_bib0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5830\/CVJA-2012-076","article-title":"Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study","volume":"24","author":"Zhang","year":"2013","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.ahj.2024.05.012_bib0004","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/heartjnl-2018-313171","article-title":"Community study to uncover the full spectrum of rheumatic heart disease in Uganda","volume":"105","author":"Scheel","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2024.05.012_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/heartjnl-2018-313810","article-title":"Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting","volume":"105","author":"Beaton","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2024.05.012_bib0006","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa2102074","article-title":"Secondary antibiotic prophylaxis for latent rheumatic heart disease","volume":"386","author":"Beaton","year":"2022","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ahj.2024.05.012_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gheart.2014.10.001","article-title":"A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda","volume":"10","author":"Huck","year":"2015","journal-title":"Glob Heart"},{"key":"10.1016\/j.ahj.2024.05.012_bib0008","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5830\/CVJA-2013-022","article-title":"Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital: cardiovascular topics","volume":"24","author":"Musoke","year":"2013","journal-title":"Cardiovasc J of Afr"},{"key":"10.1016\/j.ahj.2024.05.012_bib0009","article-title":"Rheumatic heart disease treatment cascade in Uganda","volume":"10","author":"Longenecker","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.05.012_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/CRD.0000000000000065","article-title":"Approaches to improving adherence to secondary prophylaxis for rheumatic fever and rheumatic heart disease","volume":"24","author":"R\u00e9mond","year":"2016","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ahj.2024.05.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009164","article-title":"Examining the Ugandan health system's readiness to deliver rheumatic heart disease-related services","volume":"15","author":"Ndagire","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ahj.2024.05.012_bib0012","article-title":"Penicillin for secondary prevention of rheumatic fever","volume":"3","author":"Manyemba","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ahj.2024.05.012_bib0013","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.109.191959","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.05.012_bib0014","first-page":"212","article-title":"Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever-a systematic review","volume":"93","author":"Manyemba","year":"2003","journal-title":"S Afr Med J"},{"key":"10.1016\/j.ahj.2024.05.012_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/heartasia-2017-010981","article-title":"Impact of regionalisation of a national rheumatic heart disease registry: the Ugandan experience","volume":"10","author":"Okello","year":"2018","journal-title":"Heart Asia"},{"key":"10.1016\/j.ahj.2024.05.012_bib0016","first-page":"1","article-title":"2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease","volume":"21","author":"Rwebembera","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ahj.2024.05.012_bib0017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jpc.12400","article-title":"Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board","volume":"50","author":"Russell","year":"2014","journal-title":"J Paediatr Child H"},{"key":"10.1016\/j.ahj.2024.05.012_bib0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF03262496","article-title":"Long-term treatment acceptance: what is it, and how can it be assessed?","volume":"5","author":"Marant","year":"2012","journal-title":"Patient"},{"key":"10.1016\/j.ahj.2024.05.012_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-018-0962-3","article-title":"Assessing patients\u2019 acceptance of their medication to reveal unmet needs: results from a large multi-diseases study using a patient online community","volume":"16","author":"Lambert","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ahj.2024.05.012_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40271-016-0187-7","article-title":"Item reduction, scoring, and first validation of the acceptance by the Patients of their Treatment (ACCEPT\u00a9) Questionnaire","volume":"10","author":"Arnould","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.ahj.2024.05.012_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-2-1","article-title":"Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ahj.2024.05.012_bib0022","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/archdischild-2018-315594","article-title":"Health-related quality of life in surgical children and adolescents with congenital heart disease compared with their age-matched healthy sibling: a cross-sectional study from a lower middle-income country, Pakistan","volume":"104","author":"Ladak","year":"2019","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.ahj.2024.05.012_bib0023","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40273-021-01101-x","article-title":"Developing the EQ-5D-5L value set for Uganda using the \u2018lite\u2019protocol","volume":"40","author":"Yang","year":"2022","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ahj.2024.05.012_bib0024","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3389\/fphar.2017.00843","article-title":"Fatal and near-fatal non-allergic reactions in patients with underlying cardiac disease receiving benzathine penicillin G in Israel and Switzerland","volume":"8","author":"Berkovitch","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ahj.2024.05.012_bib0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","article-title":"Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement","volume":"8","author":"Wyber","year":"2013","journal-title":"Glob heart"},{"key":"10.1016\/j.ahj.2024.05.012_bib0026","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jaci.2012.08.021","article-title":"Allergy to \u03b2-lactam antibiotics","volume":"130","author":"Solensky","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ahj.2024.05.012_bib0027","first-page":"159","article-title":"Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock","volume":"38","author":"Idsoe","year":"1968","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ahj.2024.05.012_bib0028","unstructured":"Sciences UDoHaH. Common terminology criteria for adverse events (CTCAE) version 5.0. 2017;2024. Accessed 14th May 2024."},{"key":"10.1016\/j.ahj.2024.05.012_bib0029","first-page":"1308","article-title":"Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever","volume":"337","author":"Group","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.05.012_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1081-1206(10)60402-4","article-title":"Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy","volume":"100","author":"Goldberg","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ahj.2024.05.012_bib0031","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.05.012_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002160","article-title":"Comparison of approaches to determine echocardiographic outcomes for children with latent rheumatic heart disease","volume":"9","author":"Rwebembera","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.ahj.2024.05.012_bib0033","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S0266462313000160","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) statement","volume":"29","author":"Husereau","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.ahj.2024.05.012_bib0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","article-title":"Cost-effectiveness analysis alongside clinical trials II\u2014an ISPOR good research practices task force report","volume":"18","author":"Ramsey","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.ahj.2024.05.012_bib0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2024.05.012_bib0036","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13075-022-02829-3","article-title":"Global burden of rheumatic heart disease: trends from 1990 to 2019","volume":"24","author":"Ou","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ahj.2024.05.012_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.941917","article-title":"The projections of global and regional rheumatic heart disease burden from 2020 to 2030","volume":"9","author":"Hu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ahj.2024.05.012_bib0038","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1573403X13666170116120828","article-title":"Adherence to secondary prophylaxis for acute rheumatic fever and rheumatic heart disease: a systematic review","volume":"13","author":"M Kevat","year":"2017","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.ahj.2024.05.012_bib0039","first-page":"2116","article-title":"Adherence to penicillin treatment is essential for effective secondary prevention of rheumatic heart disease: a systematic review and meta-analysis","volume":"86","author":"Ambari","year":"2024","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.ahj.2024.05.012_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1546-0096-8-22","article-title":"Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever","volume":"8","author":"Pelajo","year":"2010","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.ahj.2024.05.012_bib0041","first-page":"521","article-title":"Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community","volume":"29","author":"Eissa","year":"2005","journal-title":"ANZJPH"},{"key":"10.1016\/j.ahj.2024.05.012_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-13-131","article-title":"Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study","volume":"13","author":"Gasse","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ahj.2024.05.012_bib0043","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1573403X1503190506120953","article-title":"Adherence to secondary prophylaxis among patients with acute rheumatic fever and rheumatic heart disease","volume":"15","author":"Woods","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.ahj.2024.05.012_bib0044","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1573403X13666170116120828","article-title":"Adherence to secondary prophylaxis for acute rheumatic fever and rheumatic heart disease: a systematic review","volume":"13","author":"Kevat","year":"2017","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.ahj.2024.05.012_bib0045","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.3390\/ijerph18052477","article-title":"Interventions to improve adherence to antiretroviral therapy (ART) in sub-Saharan Africa: an updated systematic review","volume":"18","author":"Damulak","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ahj.2024.05.012_bib0046","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12879-015-1265-5","article-title":"Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda","volume":"15","author":"Nabukeera-Barungi","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ahj.2024.05.012_bib0047","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1186\/s12889-020-09430-w","article-title":"Multi-measure assessment of adherence to antiretroviral therapy among children under five years living with HIV in Jinja, Uganda","volume":"20","author":"Ssanyu","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ahj.2024.05.012_bib0048","doi-asserted-by":"crossref","first-page":"e78243","DOI":"10.1371\/journal.pone.0078243","article-title":"Adherence to antiretroviral therapy in Jinja, Uganda: a six-year follow-up study","volume":"8","author":"Mbonye","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2024.05.012_bib0049","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.idc.2009.06.008","article-title":"Pharmacokinetics and pharmacodynamics of antibacterial agents","volume":"23","author":"Levison","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ahj.2024.05.012_bib0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archpedi.1973.02110190044008","article-title":"Penicillin phenoxymethyl. Use in rheumatic fever prophylaxis","volume":"126","author":"Phair","year":"1973","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ahj.2024.05.012_bib0051","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.05.012_bib0052","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/cid\/cis629","article-title":"Infectious Diseases Society of A. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ahj.2024.05.012_bib0053","doi-asserted-by":"crossref","first-page":"e00962","DOI":"10.1128\/aac.00962-23","article-title":"Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study","volume":"67","author":"Kado","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ahj.2024.05.012_bib0054","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13346-018-0482-z","article-title":"Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD)","volume":"8","author":"Montagnat","year":"2018","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.ahj.2024.05.012_bib0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpb.2023.06.006","article-title":"Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease","volume":"189","author":"Barr","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ahj.2024.05.012_bib0057","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/inthealth\/ihad087","article-title":"Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages","volume":"16","author":"Seghers","year":"2024","journal-title":"Int Health"},{"key":"10.1016\/j.ahj.2024.05.012_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-006961","article-title":"Shortage of essential antimicrobials: a major challenge to global health security","volume":"6","author":"Shafiq","year":"2021","journal-title":"BMJ Glob Health"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T13:34:10Z","timestamp":1732368850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870324001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":57,"alternative-id":["S0002870324001273"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2024.05.012","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial)","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2024.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}